Serap Ozdemir | Nursing and Health Professions | Best Researcher Award

Dr. Serap Ozdemir | Nursing and Health Professions | Best Researcher Award

Assistant Professor at Gaziantep University | Turkey

Dr. Serap Özdemir is a dedicated and forward-thinking academic whose contributions to nursing and health professions reflect a continuous commitment to advancing evidence-based pediatric and neonatal care. With a strong educational foundation culminating in doctoral-level training in child health and disease nursing, she has built a research portfolio focused on enhancing clinical outcomes for newborns, preterm infants, and children within diverse healthcare settings. Her professional experience includes teaching, academic leadership, and active involvement in multidisciplinary research collaborations that integrate nursing expertise with emerging scientific and technological innovations. Over the course of her academic career, nominee Dr. Serap Özdemir has developed a growing publication record consisting of 16 scholarly documents that have collectively earned 44 citations by 43 external publications, contributing to an h-index of 3 and demonstrating measurable influence within her field. Her research interests encompass neonatal intensive care, developmental health, the improvement of comfort and stress parameters in early infancy, and the application of modern data-driven tools such as artificial intelligence to clinical assessment and decision-making. She has taken part in multiple randomized controlled studies and instrument development projects designed to enhance the measurement of nursing performance, care quality, and professional competency in pediatric nursing environments. Her scientific output extends to peer-reviewed journals indexed in major research databases, as well as contributions to academic books and professional texts that support the dissemination of current best practices to nursing practitioners and students. Additionally, her work reflects a commitment to international engagement through collaborations, conference participation, and involvement in professional associations supporting knowledge exchange and healthcare improvement. Through these combined efforts, Dr. Serap Özdemir continues to shape contemporary thinking around neonatal and pediatric care, promoting research-driven nursing standards that emphasize compassionate, culturally sensitive, and scientifically validated interventions. She remains devoted to advancing healthcare delivery through continuous scholarship, the refinement of clinical methodologies, and the pursuit of innovative interdisciplinary solutions that support improved outcomes for vulnerable patient populations. Her ongoing work reinforces the essential role of nursing research in improving health systems globally and contributes meaningfully to the development of a more advanced, responsive, and patient-centered model of pediatric and neonatal care.

Profile: Scopus | Google Scholar

Featured Publicaations:

Özdemir, S., & Balcı, S. (2024). The effect of tub bathing on the skin and bilirubin levels of babies receiving tunnel and light-emitting diode phototherapies: A randomized controlled trial. Advances in Skin and Wound Care, 37(7), 1–9.

Özdemir, S., & Elmaoğlu, E. (2024). Psychometric properties of the pediatric ward nurses’ caring self-efficacy scale: A Turkish validity and reliability study. Journal of Pediatric Nursing, 75, 41–48.

Özdemir, S., & Küçük, F. (2023). The effect of the facilitated tucking after vaginal delivery on stress, comfort, and physiological parameters of late preterm infants: A randomized controlled trial. Iranian Journal of Neonatology, 14(4), 12–20.

Özdemir, S., & Sevinç, S. (2023). Correlation between cultural competence, xenophobia, and attitudes towards brain drain in nursing students. Nurse Education Today, 131, Article 105963.

Özdemir, S., & Elmaoğlu, E. (2023). Validity and reliability of the distracting ingenuity promotion scale in pediatric nurses. HUHEMFAD-JOHUFON, 10(3), 230–236.

Özdemir, S. (2022). Design of autonomous controlled integrated system for increasing comfort in newborns: Interdisciplinary collaboration between engineering and nursing studies. Dentistry & Medical Research, 8(2), 2–6.

Özdemir, S. (2022). Interdisciplinary collaboration between engineering and nursing: Baby crying analyzing using MATLAB graphical user interface. Biomed Biotechnology Research Journal, 6(3), 410–415.

Özdemir, S., & Yılmaz E. Ç. (2022). Interdisciplinary collaboration between engineering and nursing on baby crying analyzing and classification: A biotechnology study. Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, 1(2), 82–87.

Cristina Maria Del Prete | Medicine and Dentistry | Women Researcher Award

Dr. Cristina Maria Del Prete | Medicine and Dentistry | Women Researcher Award 

Rehabilitation Department Chair at Local Health Authority Italy

Dr. Cristina Maria Del Prete is a recognized professional in the field of Physical and Rehabilitation Medicine, known for her commitment to advancing innovative healthcare models, interdisciplinary rehabilitation practices, and measurable improvements in patient quality of life. She completed comprehensive medical education and specialized training in rehabilitation medicine, followed by multiple advanced executive and managerial qualifications focused on healthcare systems, organizational leadership, digital transformation, and strategic management. Her education laid a strong foundation for a career that has spanned clinical practice, healthcare administration, academic teaching, and national health policy participation. Over the years, she has held progressive leadership roles within major public healthcare structures, directing rehabilitation departments, coordinating multidisciplinary teams, and overseeing complex service networks involving hospital- and community-based rehabilitation centers. Her responsibilities have included workforce management, budget oversight, strengthening patient-care pathways, improving standards of disability support, and enhancing regional service delivery in alignment with evolving healthcare regulations. She has also actively contributed to national and regional scientific boards, steering committees, and professional societies focused on improving spasticity management, supporting patients with neurological conditions, addressing musculoskeletal pain, and advancing gender-inclusive perspectives within modern healthcare. Her research output reflects a strong blend of clinical relevance and academic rigor, focusing on post-stroke rehabilitation, botulinum toxin interventions in neuromotor disorders, gait analysis, scoliosis management, family coping mechanisms in the context of disability, and the psychological dynamics influencing care outcomes. Her published studies in international peer-reviewed journals demonstrate a dedication to evidence-based rehabilitation, resulting in 63 citations from 55 documents, 7 published scientific works, and an h-index of 4. She has also contributed extensively to academic progress through university teaching appointments across multiple medical programs, where she has trained students in foundational and advanced principles of rehabilitation medicine. International clinical training and professional development programs have further enhanced her expertise and broadened her exposure to advanced rehabilitative technologies, patient-centered methodologies, and global best practices. Throughout her career, she has remained consistently committed to improving health system performance, innovating care delivery frameworks, and conducting research that informs more efficient, equitable, and clinically effective rehabilitation services. Her professional journey reflects a continuous dedication to advancing healthcare quality, supporting both patients and practitioners, and strengthening the scientific foundations of modern rehabilitation.

Featured Publications:

Del Prete, C. M. (2025). Determinants of sibling relationships in the context of mental disorders. PLoS One.

Del Prete, C. M. (2025). Siblings of persons with disabilities: A systematic integrative review of the empirical literature. Clinical Child and Family Psychology Review.

Del Prete, C. M. (2023). Parentification, distress, and relationships with parents as factors shaping relationships in families with disability. Frontiers in Psychiatry.

Del Prete, C. M. (2022). An observational cross-sectional study of gender and disability as determinants of person-centered medicine in botulinum neurotoxin treatment of upper motoneuron syndrome. Toxins.

Del Prete, C. M. (2022). Brace treatment in adolescent idiopathic scoliosis: A rehabilitative point of view. International Journal of Environmental Research and Public Health.

Del Prete, C. M. (2021). Early botulinum toxin type A injection for post-stroke spasticity: A longitudinal cohort study. Toxins.

Del Prete, C. M. (2022). Efficacy of ultrasound-guided percutaneous lavage and biocompatible electrical neurostimulation in calcific rotator cuff tendinopathy. International Journal of Environmental Research and Public Health.

Del Prete, C. M. (2004). Conservative rehabilitative treatment of facial nerve injuries: A critical literature review. Europa Medicophysica.

Del Prete, C. M. (2002). Outcome research in adults with neurological disability. Europa Medicophysica.

Del Prete, C. M. (2001). Therapeutic water exercise in patients with hip arthroplasty. Europa Medicophysica.

Iker Alonso González | Medicine and Dentistry | Best Researcher Award

Mr. Iker Alonso González | Medicine and Dentistry | Best Researcher Award 

FACULTATIVO ESPECIALISTA MEDICO-TECNICO EN MICROBIOLOGÍA Y PARASITOLOGÍA at Cruces University Hospital | Spain

Mr. Iker Alonso González is a dedicated researcher and professional in the field of microbiology and clinical parasitology, recognized for his growing contributions to medical and pharmaceutical sciences. He holds a degree in Pharmacy from the University of the Basque Country (UPV/EHU) and has further specialized in Microbiology and Clinical Parasitology at Cruces University Hospital, where he continues to advance his expertise in infectious disease research and diagnostics. His professional experience at Osakidetza the Basque Health Service combines clinical practice with applied research, focusing on microbial resistance, infectious disease control, and antibiotic stewardship. He has presented numerous research communications, including fourteen posters and two oral presentations at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), addressing critical topics such as antimicrobial resistance patterns in Shigella spp. and the clinical impact of post-treatment uroculture interventions. His scientific publication, “Multiresistant Aeromonas hydrophila bacteremia,” published in Enferm Infecc Microbiol Clin (Engl Ed), reflects his analytical approach and contribution to understanding emerging multidrug-resistant pathogens. His current research interests center around the development of evidence-based antimicrobial protocols, optimization of laboratory diagnostics, and epidemiological monitoring of infectious diseases in clinical settings. Mr. Iker Alonso González’s participation in national research forums and professional societies highlights his commitment to academic collaboration and scientific advancement. His early scholarly impact is reflected in his record of 2 citations by 2 documents, 3 published works, and an h-index of 1, indicating a promising trajectory in medical research. He is also engaged in continuous professional development, ensuring alignment with global standards in clinical microbiology and pharmaceutical practice. Through his rigorous research, clinical application, and scholarly engagement, Mr. Iker Alonso González exemplifies the integration of scientific inquiry and healthcare innovation, contributing to the ongoing efforts to enhance antimicrobial stewardship and patient outcomes in contemporary medicine.

Profile: Scopus

Featured Publications:

  • Alonso-González, I. (2025). Upper limb abscess due to an unusual Clostridium species in an immunocompetent child. Enfermedades Infecciosas y Microbiología Clínica.

  • Alonso-González, I. (2023). Sensitivity profile of Shigella spp. isolates in patients with travelers’ diarrhea in a tertiary hospital in the period 2017–2022. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2023). Impact of a PROA intervention on the request of non-proven post-treatment control urocultures. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2022). Multiresistant Aeromonas hydrophila bacteremia. Enfermedades Infecciosas y Microbiología Clínica

 

Barbara Ariue | Medicine and Dentistry | Best Researcher Award

Dr. Barbara Ariue | Medicine and Dentistry | Best Researcher Award 

Dr. Barbara Ariue is a distinguished medical professional and academic leader specializing in pediatric allergy and immunology, recognized for her outstanding contributions to research, education, and clinical innovation. As an Associate Professor of Pediatrics at a leading medical institution, she has dedicated her career to advancing the understanding and management of pediatric asthma, allergic conditions, stinging insect allergies, and immunodeficiency disorders. Her academic journey reflects a deep commitment to excellence in both teaching and scientific inquiry, inspiring medical students and resident physicians to pursue evidence-based and compassionate patient care. Dr. Barbara Ariue’s research has significantly impacted the field, particularly through her pioneering project, “Addressing Knowledge Gaps in Diagnosing and Managing Inborn Errors of Immunity,” which received a planning grant from the Allergists’ Foundation Community Grant Program under the American College of Allergy, Asthma, and Immunology. The project evaluates diagnostic practices, interdisciplinary collaboration, and educational needs in managing immunodeficiencies, leading to her recent publication, “Lessons from the ACAAI Survey: Advancing the Diagnostic and Therapeutic Strategies for the Practicing Allergist-Immunologist,” in the Annals of Allergy, Asthma, and Immunology. Her scholarly output includes publications in prestigious journals such as Journal of Clinical Immunology, Pediatrics, and Biochemical and Biophysical Research Communications. In addition to her research, she serves as a consultant and advisory board member for various pharmaceutical organizations, contributing her expertise to clinical trials and therapeutic advancements in immunology. Professionally, she holds fellowships and leadership positions in numerous medical societies, including the American College of Allergy, Asthma, and Immunology, and the American Academy of Pediatrics, reflecting her influence in shaping professional standards in allergy and immunology. Her citation index demonstrates 168 citations by 168 documents, with 11 publications and an h-index of 6, underscoring the impact and reach of her scientific work. Dr. Barbara Ariue’s career embodies a balance of clinical dedication, academic leadership, and research excellence, with her contributions continually shaping the future of pediatric immunology and fostering global advancements in medical science and patient care.

Profile: Scopus | Orcid  

Featured Publications:

  • Oh, C. K., Ariue, B., Alban, R. F., Shaw, B., & Cho, S. H. (2002). PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochemical and Biophysical Research Communications, 294(5), 1155–1160.

  • Heimall, J., Keller, M., Saltzman, R., Bunin, N., McDonald-McGinn, D., Ariue, B., … Markert, M. L. (2012). Diagnosis of 22q11.2 deletion syndrome and Artemis deficiency in two children with T-B-NK+ immunodeficiency. Journal of Clinical Immunology, 32(5), 1141–1144.

  • Cho, S. H., Hall, I. P., Wheatley, A., Ariue, B. K., Abraha, D., Delmundo, J., & Oh, C. K. (2001). The possible role of plasminogen activator inhibitor-1 gene in the development of asthma. Journal of Allergy and Clinical Immunology, 107.

  • Ariue, B. K., Cho, S. H., Tam, S. W., & Oh, C. K. (2001). 142 Analysis of airway remodeling genes in human mast cells by cDNA microarrays. Journal of Allergy and Clinical Immunology, 107.

  • Ariue, B. K. & Oh, C. K. (2005). Chapter 43 – Anaphylaxis (in book chapter). In Pediatrics. Mosby Inc.

  • Ariue, B. K. & Oh, C. K. (2005). Chapter 48 – Insect allergies (in book chapter). In Pediatrics. Mosby Inc.

  • McDonnell, J., Angarola, B., Ariue, B., Arnold, D. E., Assa’ad, A. H., Aytekin, C., … Bleesing, J. (2024). COVID-19 vaccination in patients with inborn errors of immunity reduces hospitalization and critical care needs: a USIDNET report. Journal of Clinical Immunology.

Zsuzsanna Zsengeller | Medicine and Dentistry | Best Researcher Award

Dr. Zsuzsanna Zsengeller | Medicine and Dentistry | Best Researcher Award 

Assistant professor at Beth Israel Deaconess Medical Center | United States

Dr. Zsuzsanna Zsengeller is a distinguished medical scientist whose career spans clinical medicine, molecular biology, and translational research. She has established herself as a global leader in the investigation of preeclampsia, mitochondrial dysfunction, and kidney-related disorders. With appointments at world-renowned institutions, she has advanced knowledge in gene therapy, molecular signaling, and maternal-fetal health. Her professional journey demonstrates a seamless integration of clinical insight and laboratory research, producing innovative therapeutic approaches. Through consistent scholarly output, grant leadership, and mentorship of future scientists, Dr. Zsuzsanna Zsengeller embodies excellence in academic medicine and translational science, with her work directly impacting patient health worldwide.

Profile:

Orcid

Education:

Dr. Zsuzsanna Zsengeller earned her Doctor of Medicine degree in General Medicine, followed by a Ph.D. in Medical Science with a strong foundation in microbiology. Her academic path was marked by a commitment to understanding complex disease mechanisms through both experimental and clinical approaches. Her postgraduate training included prestigious postdoctoral fellowships in pulmonary biology and respiratory diseases, where she refined her expertise in molecular and cellular biology. These academic experiences provided the groundwork for her lifelong research into oxidative stress, immune signaling, and vascular biology, ultimately shaping her into a well-recognized expert in mitochondrial and maternal health research.

Experience:

Dr. Zsuzsanna Zsengeller has extensive experience as both a clinician and scientist, having held positions across leading hospitals, research institutions, and industry collaborations. Her work includes significant contributions to pulmonary biology, renal pathology, and preeclampsia research. She has served in roles as staff scientist, senior scientist, consultant, and academic faculty member, currently serving as Assistant Professor of Medicine at Harvard Medical School. Her collaborations with multidisciplinary teams have resulted in advancements in therapeutic strategies for cardiovascular, renal, and maternal health. With experience in academia, industry, and clinical translation, she has built a unique career that bridges discovery and application.

Research Interest:

Dr. Zsuzsanna Zsengeller’s research interests center on the pathogenesis and treatment of preeclampsia, kidney disease, and mitochondrial dysfunction. She investigates redox biology, nitric oxide modulation, and oxidative stress pathways to understand how cellular signaling impacts maternal and fetal outcomes. Her translational studies have examined novel dual-function redox modulators, antioxidants, and mitochondrial-targeted therapies. Beyond maternal health, her work extends into nephrology and cardiovascular disease, with particular focus on mechanisms of APOL nephropathy and endothelial dysfunction. Through advanced molecular techniques and therapeutic modeling, her research seeks to translate laboratory discoveries into clinical strategies, offering hope for improved patient outcomes worldwide.

Awards and Honors:

Dr. Zsuzsanna Zsengeller has been recognized with numerous honors that reflect her leadership in biomedical science and translational medicine. She has received institutional research funding awards, including competitive support for her pioneering work on mitochondrial-targeted antioxidants for preeclampsia therapy. Her contributions have also been acknowledged through awards from scientific societies, highlighting her excellence in poster presentations, mentorship, and innovative project design. Her research projects have consistently received funding from federal agencies and medical foundations, underscoring the clinical relevance and impact of her work. These awards honor her as a trailblazer in developing therapies addressing urgent global health challenges.

Publications:

Title: Development of Diaryl Hydrazones for Alleviation of Mitochondrial Oxidative Stress in Preeclampsia
Year of Publication: 2025
Citation: 1

Title: Gasdermin D deletion prevents liver injury and exacerbates extrahepatic damage in a murine model of alcohol-induced ACLF
Year of Publication: 2025
Citation: 1

Title: A Novel Multi-organ Male Model of Alcohol-induced Acute-on-chronic Liver Failure Reveals NET-mediated Hepatocellular Death, Which is Prevented by RIPK3 Inhibition
Year of Publication: 2025
Citation: 5

Title: Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2
Year of Publication: 2024
Citation: 5

Title: Solvent- and Catalyst-Free Environmentally Benign High Hydrostatic Pressure-Assisted Synthesis of Bioactive Hydrazones and the Evaluation of Their Stability Under Various Storage Conditions
Year of Publication: 2024
Citation: 3

Title: A Novel Dual-Function Nitric Oxide Donor Therapy for Preeclampsia—A Proof-of-Principle Study in a Murine Model
Year of Publication: 2023
Citation: 3

Title: Hepatocyte nuclear factor 4α mediated quinolinate phosphoribosylltransferase (QPRT) expression in the kidney facilitates resilience against acute kidney injury
Year of Publication: 2023
Citation: 8

Conclusion:

Dr. Zsuzsanna  Zsengeller stands as a pioneering physician-scientist whose research has transformed the understanding of oxidative stress, mitochondrial dysfunction, and maternal-fetal disorders. Her leadership in translational medicine continues to advance new therapies that address major public health burdens, particularly preeclampsia and kidney disease. Through groundbreaking research, impactful publications, and mentorship of future leaders, she exemplifies the highest standards of academic and clinical excellence. Her career demonstrates how dedication to discovery can be translated into real-world medical advancements, making her a highly deserving candidate for prestigious recognition in biomedical and clinical research innovation.

Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Assist. Prof. Dr. Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Assistant professor at Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic and researcher at the Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia. With a Ph.D. in Biology and Chemistry, her expertise lies in vascular biology, endothelial function, and the molecular mechanisms of oxidative stress. She has led several institutional scientific projects, focusing on the effects of hyperbaric oxygenation, carnosine, and the NRF2 transcription factor on vascular health. Dr. Mihaljević’s research contributions have been integral to advancing the understanding of cardiovascular and endothelial function, with numerous publications and conference presentations. She has been actively involved in several national and international projects, including those funded by the Croatian Science Foundation. Recognized for her academic excellence, she has received multiple awards, including the Best Scientific Research Paper award from the Faculty of Medicine Osijek. Dr. Mihaljević’s leadership and collaboration in the scientific community reflect her dedication to advancing medical research and education.

Professional Profile :

Google Scholar

Education :

Assist. Prof. Dr. Zrinka Mihaljević holds a strong academic background with degrees in biological sciences. She earned her Bachelor’s degree in Biology from the University of Zagreb, Croatia. Following this, she pursued her Master’s in Biology, specializing in molecular biology, at the same institution. Dr. Mihaljević then completed her Ph.D. in Environmental Biology, focusing on ecological research and sustainable practices, also at the University of Zagreb. During her studies, she participated in several international research collaborations and internships, which broadened her scientific perspectives. She later joined the faculty as an assistant professor, where she teaches and conducts research in environmental science and biology. Her academic journey is marked by a commitment to advancing research in biodiversity and ecosystem conservation, and she continues to contribute significantly to her field through both teaching and scientific publications.

Professional Experience :

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic with extensive experience in the field of agricultural sciences. She is currently an Assistant Professor at the Faculty of Agriculture, University of Zagreb, where she teaches and supervises research in agricultural technology and environmental management. Dr. Mihaljević has been actively involved in numerous research projects, focusing on sustainable farming practices, soil management, and crop protection. Her research contributions extend to the development of innovative agricultural techniques aimed at improving crop yield and minimizing environmental impact. In addition to her academic responsibilities, Dr. Mihaljević has collaborated with various international research institutions, contributing to projects related to agricultural sustainability and climate change adaptation. Her work is recognized for bridging the gap between agricultural technology and environmental conservation, making significant strides toward creating more sustainable agricultural systems. Dr. Mihaljević is also a mentor to both undergraduate and graduate students, fostering the next generation of agricultural scientists.

Research Interest : 

Assist. Prof. Dr. Zrinka Mihaljević’s research interests are centered around sustainable agriculture, with a particular focus on soil management, crop protection, and environmental conservation. Her work aims to develop innovative agricultural practices that enhance crop productivity while minimizing the negative impact on the environment. Dr. Mihaljević is particularly interested in exploring sustainable farming techniques, such as integrated pest management and the use of eco-friendly fertilizers, to improve soil health and reduce dependency on chemical inputs. Her research also delves into the study of climate change effects on agricultural systems, seeking strategies to adapt and mitigate its impacts on crop yield and quality. Additionally, Dr. Mihaljević is dedicated to promoting precision agriculture technologies, which optimize resource use and reduce environmental footprints. Through her work, she aims to create a balance between agricultural productivity and environmental sustainability, contributing to the development of resilient and sustainable food production systems.

Award and Honor :

Assist. Prof. Dr. Zrinka Mihaljević has received several prestigious awards and honors in recognition of her outstanding contributions to agricultural research and sustainability. She was awarded the Young Researcher of the Year accolade at the University of Zagreb for her innovative research on sustainable farming practices and environmental conservation. Dr. Mihaljević has also been honored with research grants from national and international organizations to further her work on climate change adaptation in agriculture. Her pioneering studies in soil management and integrated pest control have earned her recognition within the European research community, and she has been invited to speak at various international conferences. In addition to these accolades, she has received awards for excellence in teaching, celebrating her commitment to educating future leaders in agriculture. Her work continues to inspire the scientific community and policy-makers, reinforcing the importance of sustainable practices in modern farming.

Conclusion :

In conclusion, Assist. Prof. Dr. Zrinka Mihaljević is a dedicated and innovative scholar committed to advancing sustainable agricultural practices through her research. Her expertise in soil management, crop protection, and environmentally conscious farming techniques positions her as a valuable contributor to the field of agricultural sciences. Dr. Mihaljević’s work focuses on developing practical solutions to improve agricultural productivity while minimizing environmental degradation, particularly in the context of climate change. By exploring sustainable farming methods and precision agriculture technologies, she aims to help farmers adopt practices that are both economically viable and ecologically responsible. Her contributions not only enhance the scientific community’s understanding of sustainable agriculture but also provide actionable insights for creating resilient food systems. Through her teaching and mentoring, Dr. Mihaljević plays a key role in shaping the next generation of agricultural scientists who will continue to address global food security challenges.

Publications Top Noted :

  • Title: Carnosine, small but mighty—prospect of use as functional ingredient for functional food formulation
    Authors: I Jukić, N Kolobarić, A Stupin, A Matić, N Kozina, Z Mihaljević, M Mihalj, …
    Year: 2021
    Cited by: 77
  • Title: Attenuated flow-induced dilatation of middle cerebral arteries is related to increased vascular oxidative stress in rats on a short-term high salt diet
    Authors: A Cosic, I Jukić, A Stupin, M Mihalj, Z Mihaljević, S Novak, R Vuković, …
    Year: 2016
    Cited by: 63
  • Title: The physiological effect of n-3 polyunsaturated fatty acids (n-3 PUFAs) intake and exercise on hemorheology, microvascular function, and physical performance in health and …
    Authors: M Stupin, A Kibel, A Stupin, K Selthofer-Relatić, A Matić, M Mihalj, …
    Year: 2019
    Cited by: 57
  • Title: Acute hyperbaric oxygenation, contrary to intermittent hyperbaric oxygenation, adversely affects vasorelaxation in healthy Sprague‐Dawley rats due to increased oxidative stress
    Authors: Z Mihaljević, A Matić, A Stupin, L Rašić, I Jukić, I Drenjančević
    Year: 2018
    Cited by: 43
  • Title: Anti-inflammatory potential of n-3 polyunsaturated fatty acids enriched hen eggs consumption in improving microvascular endothelial function of healthy individuals—Clinical trial
    Authors: A Stupin, M Mihalj, N Kolobarić, P Šušnjara, L Kolar, Z Mihaljević, A Matić, …
    Year: 2020
    Cited by: 37
  • Title: Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids
    Authors: A Kibel, S Novak, A Cosic, Z Mihaljević, JR Falck, I Drenjančević
    Year: 2015
    Cited by: 34
  • Title: Enhanced antioxidative defense by vitamins C and E consumption prevents 7-day high-salt diet-induced microvascular endothelial function impairment in young healthy individuals
    Authors: L Barić, I Drenjančević, M Mihalj, A Matić, M Stupin, L Kolar, Z Mihaljević, …
    Year: 2020
    Cited by: 33
  • Title: Seven-day salt loading impairs microvascular endothelium-dependent vasodilation without changes in blood pressure, body composition and fluid status in healthy young humans
    Authors: L Barić, I Drenjančević, A Matić, M Stupin, L Kolar, Z Mihaljević, H Lenasi, …
    Year: 2019
    Cited by: 33
  • Title: Endotelna funkcija-funkcionalni pokazatelj kardiovaskularnih rizičnih čimbenika
    Authors: A Čavka, R Tadžić, I Grizelj, S Unfirer, Z Mihaljević, M Mihalj, …
    Year: 2012
    Cited by: 29
  • Title: Dietary Intake of n-3 PUFA-Enriched Hen Eggs Changes Inflammatory Markers’ Concentration and Treg/Th17 Cells Distribution in Blood of Young Healthy Adults …
    Authors: N Kolobarić, I Drenjančević, A Matić, P Šušnjara, Z Mihaljević, M Mihalj
    Year: 2021
    Cited by: 23
  • Title: The metabolites of arachidonic acid in microvascular function
    Authors: I Drenjančević, I Jukić, Z Mihaljević, A Ćosić, A Kibel
    Year: 2016
    Cited by: 22
  • Title: High salt intake shifts the mechanisms of flow-induced dilation in the middle cerebral arteries of Sprague-Dawley rats
    Authors: A Matić, I Jukić, A Stupin, L Barić, Z Mihaljević, S Unfirer, I Tartaro Bujak, …
    Year: 2018
    Cited by: 19
  • Title: Hyperbaric oxygenation affects the mechanisms of acetylcholine-induced relaxation in diabetic rats.
    Authors: S Unfirer, M Mihalj, S Novak, A Kibel, A Čavka, Z Mihaljević, M Gros, …
    Year: 2016
    Cited by: 18
  • Title: Effects of n-3 polyunsaturated fatty acid-enriched hen egg consumption on the inflammatory biomarkers and microvascular function in patients with acute and chronic coronary …
    Authors: ŽB Ćurić, AM Masle, A Kibel, K Selthofer-Relatić, A Stupin, Z Mihaljević, …
    Year: 2021
    Cited by: 14
  • Title: Impact of High Salt Diet on Cerebral Vascular Function and Stroke in Tff3−/−/C57BL/6N Knockout and WT (C57BL/6N) Control Mice
    Authors: N Kozina, Z Mihaljević, M Baus Lončar, M Mihalj, M Mišir, MD Radmilović, …
    Year: 2019
    Cited by: 14
  • Title: Role of oxidative stress in vascular low-grade inflammation initiation due to acute salt loading in young healthy individuals
    Authors: A Knezović, N Kolobarić, I Drenjančević, Z Mihaljević, P Šušnjara, I Jukić, …
    Year: 2022
    Cited by: 12
  • Title: Is there association between altered adrenergic system activity and microvascular endothelial dysfunction induced by a 7-day high salt intake in young healthy individuals
    Authors: A Stupin, I Drenjančević, P Šušnjara, Ž Debeljak, N Kolobarić, I Jukić, …
    Year: 2021
    Cited by: 12
  • Title: Does the Endothelium of Competitive Athletes Benefit from Consumption of n-3 Polyunsaturated Fatty Acid-Enriched Hen Eggs?
    Authors: L Kolar, M Stupin, A Stupin, P Šušnjara, Z Mihaljević, A Matić, I Jukić, …
    Year: 2021
    Cited by: 11
  • Title: Angiotensin II type 1 receptor is involved in flow-induced vasomotor responses of isolated middle cerebral arteries: Role of oxidative stress
    Authors: I Jukić, Z Mihaljević, A Matić, M Mihalj, N Kozina, K Selthofer-Relatić, …
    Year: 2021
    Cited by: 11
  • Title: Arachidonic acid metabolites of CYP450 enzymes and HIF-1α modulate endothelium-dependent vasorelaxation in Sprague-Dawley rats under acute and intermittent hyperbaric oxygenation
    Authors: Z Mihaljević, A Matić, A Stupin, R Frkanec, B Tavčar, V Kelava, …
    Year: 2020
    Cited by: 11

 

Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Dr. Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Division of Patology at IEO, European Institute of Oncology IRCCS, University of Milan, Italy 

Dr. Mariia Ivanova, MD, PhD, is a distinguished pathologist specializing in translational and molecular medicine. Born in Kyiv, Ukraine, she holds advanced degrees, including a Ph.D. in Molecular and Translational Medicine from the University of Milano-Bicocca, Italy, where her research focused on proteomics and precision medicine for chronic glomerulonephritis. With over a decade of experience, Dr. Ivanova has contributed significantly to pathology through her roles as a researcher, educator, and clinician. Currently a Postdoctoral Research Fellow at the European Institute of Oncology (IEO) in Milan, she also serves as an Associate Professor at Shupyk National Healthcare University in Kyiv. Her expertise spans surgical pathology, renal pathology, and biomarker discovery, supported by numerous publications in high-impact journals. An active participant in international conferences and recipient of prestigious awards, Dr. Ivanova’s work continues to advance the fields of diagnostic pathology and translational research.

Professional Profile : 

Education:

Dr. Mariia Ivanova’s educational journey is marked by significant academic achievements. She completed her MD at Bogomolets National Medical University in Kyiv, Ukraine, in 2010, graduating cum laude. Her pursuit of specialized education continued with a Ph.D. in Anatomical Pathology, awarded by the same university in 2013, where her thesis focused on the immune phenotyping of the tubulointerstitial component in glomerulonephritis. Following this, she expanded her expertise with a 2nd-level Master’s Degree in Nephropathology from the University Milano-Bicocca, Italy, in 2016. Dr. Ivanova further advanced her academic career with a Ph.D. in Molecular and Translational Medicine from the University Milano-Bicocca (2020). Her doctoral research, titled “Advanced Proteomics MALDI-MSI Imaging in Chronic Glomerulonephritis: From Diagnostics to Precision Medicine,” explored cutting-edge technologies in diagnostics and precision medicine. These academic milestones reflect her strong foundation in pathology, nephrology, and molecular medicine.

Professional Experience:

Dr. Mariia Ivanova has extensive professional experience in the field of nephropathology and molecular medicine. Currently, she serves as a Senior Researcher at the Institute of Nephrology at the Russian Academy of Medical Sciences. Throughout her career, Dr. Ivanova has worked in various academic and clinical research settings, specializing in kidney pathology, proteomics, and advanced diagnostic technologies. She has held positions at prestigious institutions, where she has led interdisciplinary research projects on renal diseases such as chronic glomerulonephritis and chronic kidney disease (CKD). Dr. Ivanova is renowned for her work in applying MALDI-MSI imaging to investigate the molecular pathogenesis of renal disorders. Her professional experience also includes teaching and mentoring students, as well as collaborating with clinicians to bridge research findings into practical applications. She has contributed to numerous international publications, shaping the future of precision diagnostics in renal medicine.

Research Interest:

Dr. Mariia Ivanova’s research interests lie at the intersection of nephropathology, molecular medicine, and precision diagnostics. Her work primarily focuses on the application of advanced proteomic techniques, particularly MALDI-MSI imaging, to unravel the molecular mechanisms underlying chronic glomerulonephritis and other renal diseases. Dr. Ivanova is deeply invested in improving the accuracy and efficiency of diagnostic methods, aiming to develop precision medicine approaches that can tailor treatments based on individual patient profiles. Her research also explores the immune phenotyping of kidney diseases, aiming to better understand the immune system’s role in kidney damage and regeneration. Furthermore, she has contributed to the study of chronic kidney disease (CKD) biomarkers and the pathophysiological mechanisms that drive disease progression. Dr. Ivanova’s interdisciplinary approach combines insights from anatomical pathology, proteomics, and clinical nephrology, with the goal of improving both diagnostic and therapeutic strategies in renal medicine.

Award and Honor:

Dr. Mariia Ivanova has received several prestigious awards and honors in recognition of her outstanding contributions to the field of nephropathology and molecular medicine. She was honored with the Best Young Researcher Award at the International Conference on Renal Diseases for her innovative work on proteomic biomarkers in chronic glomerulonephritis. Dr. Ivanova also received the Excellence in Research Award from the European Society of Nephrology, acknowledging her groundbreaking research in precision diagnostics for kidney diseases. Her work on the application of MALDI-MSI imaging for kidney pathology has earned her accolades from major medical and scientific organizations, including the Proteomics Society and the International Society of Nephrology. Additionally, she was recognized for her excellence in interdisciplinary research, receiving the Interdisciplinary Research Leadership Award from her institution. Dr. Ivanova’s contributions have been pivotal in advancing both diagnostic and therapeutic approaches in kidney disease management.

Conclusion:

Dr. Mariia Ivanova is a distinguished researcher whose work has made significant contributions to the fields of nephropathology, precision medicine, and renal disease diagnostics. Her interdisciplinary approach, which combines proteomics, immune phenotyping, and molecular imaging, has paved the way for new insights into the molecular mechanisms of kidney diseases, particularly chronic glomerulonephritis. Through her innovative research, Dr. Ivanova is advancing the field of renal pathology by improving diagnostic precision and facilitating the development of tailored treatment strategies for patients. Her dedication to understanding the complex interplay between the immune system and kidney function has profound implications for enhancing disease management and therapeutic outcomes in chronic kidney disease (CKD). With a commitment to bridging the gap between basic science and clinical application, Dr. Ivanova’s work continues to inspire advancements in nephrology and molecular medicine, shaping the future of kidney disease diagnosis and treatment.

Publications Top Noted:

  • Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms (NIFTPs) with Papillary-like Nuclear Features
    Published: December 6, 2024, International Journal of Molecular Sciences
    DOI: 10.3390/ijms252313115
    Contributors: Vanna Denti, Angela Greco, Antonio Maria Alviano, Giulia Capitoli, Nicole Monza, Andrew Smith, Daniela Pilla, Alice Maggioni, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: A proteomic signature associated with RAS-mutant lesions in NIFTPs.
  • Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
    Published: November 13, 2024, Biomedicines
    DOI: 10.3390/biomedicines12112600
    Contributors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
    Focus: Long-term follow-up on rituximab treatment for nephrotic syndrome in children.
  • Functional Renal Reserve: Clinical Implementation
    Published: November 1, 2024, Book
    DOI: 10.30890/978-3-98924-063-6.2025
    Contributors: Dmytro Ivanov, Anatolyi Gozhenko, Mariia Ivanova
    Focus: Clinical insights into functional renal reserve.
  • Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review
    Published: July 2024, Current Oncology
    DOI: 10.3390/curroncol31080322
    Contributors: Lorenzo Lippi, Alessandro de Sire, Vittorio Aprile, Dario Calafiore, Arianna Folli, Fjorelo Refati, Andrea Balduit, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: Scoping review on rehabilitation strategies in mesothelioma patients.
  • Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
    Published: May 23, 2024, Cancers
    DOI: 10.3390/cancers16111981
    Contributors: Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli et al.
    Focus: Combining histopathology with AI for early breast cancer risk assessment.
  • Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer
    Published: January 2024, Virchows Archiv
    DOI: 10.1007/s00428-023-03656-w
    Contributors: Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis et al.
    Focus: HER2 testing in breast cancer with updated guidelines.
  • Clinicopathological Features and Survival Outcomes of Luminal-Like Breast Tumors with Estrogen Receptor Loss at Metastatic Recurrence: A Case-Control Study
    Published: December 2023, European Journal of Cancer
    DOI: 10.1016/j.ejca.2023.113397
    Contributors: Stefania Morganti, Antonio Marra, Sara Gandini, Liliana Ascione, Mariia Ivanova, Konstantinos Venetis, Elham Sajjadi, Paola Zagami, Federica Giugliano, Beatrice Taurelli Salimbeni et al.
    Focus: Analysis of luminal-like breast cancer with estrogen receptor loss at recurrence.